Aarey Drugs & Pharmaceuticals Limited (BOM:524412)

Market Cap	2.23B +48.0%
Revenue (ttm)	4.78B +0.9%
Net Income	39.68M -1.4%
EPS	1.39 -2.1%
Shares Out	28.45M
PE Ratio	56.47
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,883
Open	78.50
Previous Close	78.63
Day's Range	76.75 - 78.50
52-Week Range	49.01 - 100.00
Beta	1.14
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About BOM:524412

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, ...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1990
• Employees: 132
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524412

Financial Performance

In fiscal year 2026, BOM:524412's revenue was 4.78 billion, an increase of 0.93% compared to the previous year's 4.74 billion. Earnings were 39.68 million, a decrease of -1.40%.